Skip to main content
Premium Trial:

Request an Annual Quote

John Schneider, Mary Tanner, Hubert Birner, Peter Fellner, Alfred Oberholz

Premium

John Schneider has joined Vitra Bioscience as vice president of marketing and business development, CBA News has learned.

Prior to joining Vitra, Schneider held roles of R&D director and VP of marketing and business development at Molecular Dynamics and Amersham Biosciences, both of which were acquired last year by GE Healthcare.


Evotec OAI said last week that Mary Tanner has been re-elected to its supervisory board, while Hubert Birner, Peter Fellner, and Alfred Oberholz have been appointed to the supervisory board.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.